Additionally, among the predicted neuroendocrine neoplasms, seven of 10 cases (70.0%) expressed the classical markers of neuroendocrine cell differentiation (Syn, CgA, and CD56), and four of five cases (80.0%) were INSM1 positive (Fig. 1). This evidence concerns the gene NCAM1 and neuroendocrine neoplasm.